Transaction to enhance Labcorp's laboratory services network. OPKO Health, Inc. is a multinational biopharmaceutical and diagnostics company. The transaction is expected to close in the second half of 2024. BioReference Health will continue to offer oncology and urology diagnostic services nationwide.